A double-blind, placebo-controlled study of remacemide hydrochloride in patients with refractory epilepsy following pre-surgical assessment
Devinsky, O, Vazquez, B, Faught, E, Leppik, I.E, Pellock, J.M, Schachter, S, Alderfer, V, Holdich, T.A.H
Published in Seizure (London, England) (01.09.2002)
Published in Seizure (London, England) (01.09.2002)
Get full text
Journal Article
Remacemide hydrochloride as an add-on therapy in epilepsy: a randomized, placebo-controlled trial of three dose levels (300, 600 and 1200 mg / day) in a Q.I.D. regimen
Chadwick, D.W, Betts, T.A, Boddie, H.G, Crawford, P.M, Lindstrom, P, Newman, P.K, Soryal, I, Wroe, S, Holdich, T.A.H
Published in Seizure (London, England) (01.03.2002)
Published in Seizure (London, England) (01.03.2002)
Get full text
Journal Article
Remacemide hydrochloride as an add-on therapy in epilepsy: a randomized, placebo-controlled trial of three dose levels (300, 600 and 800 mg / day) in a B.I.D. regimen
Jones, M.W, Blume, W.T, Guberman, A, Lee, M.A, Pillay, N, Weaver, D.F, Veloso, F, Holdich, T.A.H
Published in Seizure (London, England) (01.03.2002)
Published in Seizure (London, England) (01.03.2002)
Get full text
Journal Article